PROK2 and inflammatory bowel disease: These observations, together with the discovery that PK2 can modulate intestinal ion transport, raises the possibility that PK2 inhibitors may have some clinical utility in gastrointestinal disorders, such as irritable bowel syndrome and inflammatory bowel disease [86].